Hepatic Encephalopathy Therapeutics Market, Global Outlook and Forecast 2022-2028

February 2022 | 68 pages | ID: H31C073D292EEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Hepatic Encephalopathy Therapeutics in Global, including the following market information:

Global Hepatic Encephalopathy Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Hepatic Encephalopathy Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Kits Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hepatic Encephalopathy Therapeutics include ASKA Pharmaceutical, COSMO Pharmaceuticals, Fresenius Kabi, Mallinckrodt Pharmaceuticals, Lupin, Salix Pharmaceuticals, Teva Pharmaceutical and Bausch Health, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hepatic Encephalopathy Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hepatic Encephalopathy Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Hepatic Encephalopathy Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Kits
• Reagents
• Instruments

Global Hepatic Encephalopathy Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Hepatic Encephalopathy Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Acute Liver Failure
• Portal Systemic Bypass without Liver Disease
• Liver Cirrhosis

Global Hepatic Encephalopathy Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Hepatic Encephalopathy Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hepatic Encephalopathy Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Hepatic Encephalopathy Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• ASKA Pharmaceutical
• COSMO Pharmaceuticals
• Fresenius Kabi
• Mallinckrodt Pharmaceuticals
• Lupin
• Salix Pharmaceuticals
• Teva Pharmaceutical
• Bausch Health

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Hepatic Encephalopathy Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Hepatic Encephalopathy Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HEPATIC ENCEPHALOPATHY THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Hepatic Encephalopathy Therapeutics Market Size: 2021 VS 2028
2.2 Global Hepatic Encephalopathy Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Hepatic Encephalopathy Therapeutics Players in Global Market
3.2 Top Global Hepatic Encephalopathy Therapeutics Companies Ranked by Revenue
3.3 Global Hepatic Encephalopathy Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Hepatic Encephalopathy Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hepatic Encephalopathy Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hepatic Encephalopathy Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Hepatic Encephalopathy Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Hepatic Encephalopathy Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Hepatic Encephalopathy Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Kits
  4.1.3 Reagents
  4.1.4 Instruments
4.2 By Type - Global Hepatic Encephalopathy Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Hepatic Encephalopathy Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Hepatic Encephalopathy Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Hepatic Encephalopathy Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Hepatic Encephalopathy Therapeutics Market Size, 2021 & 2028
  5.1.2 Acute Liver Failure
  5.1.3 Portal Systemic Bypass without Liver Disease
  5.1.4 Liver Cirrhosis
5.2 By Application - Global Hepatic Encephalopathy Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Hepatic Encephalopathy Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Hepatic Encephalopathy Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Hepatic Encephalopathy Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Hepatic Encephalopathy Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Hepatic Encephalopathy Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Hepatic Encephalopathy Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Hepatic Encephalopathy Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Hepatic Encephalopathy Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Hepatic Encephalopathy Therapeutics Revenue, 2017-2028
  6.3.2 US Hepatic Encephalopathy Therapeutics Market Size, 2017-2028
  6.3.3 Canada Hepatic Encephalopathy Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Hepatic Encephalopathy Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Hepatic Encephalopathy Therapeutics Revenue, 2017-2028
  6.4.2 Germany Hepatic Encephalopathy Therapeutics Market Size, 2017-2028
  6.4.3 France Hepatic Encephalopathy Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Hepatic Encephalopathy Therapeutics Market Size, 2017-2028
  6.4.5 Italy Hepatic Encephalopathy Therapeutics Market Size, 2017-2028
  6.4.6 Russia Hepatic Encephalopathy Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Hepatic Encephalopathy Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Hepatic Encephalopathy Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Hepatic Encephalopathy Therapeutics Revenue, 2017-2028
  6.5.2 China Hepatic Encephalopathy Therapeutics Market Size, 2017-2028
  6.5.3 Japan Hepatic Encephalopathy Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Hepatic Encephalopathy Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Hepatic Encephalopathy Therapeutics Market Size, 2017-2028
  6.5.6 India Hepatic Encephalopathy Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Hepatic Encephalopathy Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Hepatic Encephalopathy Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Hepatic Encephalopathy Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Hepatic Encephalopathy Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Hepatic Encephalopathy Therapeutics Market Size, 2017-2028
  6.7.3 Israel Hepatic Encephalopathy Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Hepatic Encephalopathy Therapeutics Market Size, 2017-2028
  6.7.5 UAE Hepatic Encephalopathy Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 ASKA Pharmaceutical
  7.1.1 ASKA Pharmaceutical Corporate Summary
  7.1.2 ASKA Pharmaceutical Business Overview
  7.1.3 ASKA Pharmaceutical Hepatic Encephalopathy Therapeutics Major Product Offerings
  7.1.4 ASKA Pharmaceutical Hepatic Encephalopathy Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 ASKA Pharmaceutical Key News
7.2 COSMO Pharmaceuticals
  7.2.1 COSMO Pharmaceuticals Corporate Summary
  7.2.2 COSMO Pharmaceuticals Business Overview
  7.2.3 COSMO Pharmaceuticals Hepatic Encephalopathy Therapeutics Major Product Offerings
  7.2.4 COSMO Pharmaceuticals Hepatic Encephalopathy Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 COSMO Pharmaceuticals Key News
7.3 Fresenius Kabi
  7.3.1 Fresenius Kabi Corporate Summary
  7.3.2 Fresenius Kabi Business Overview
  7.3.3 Fresenius Kabi Hepatic Encephalopathy Therapeutics Major Product Offerings
  7.3.4 Fresenius Kabi Hepatic Encephalopathy Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Fresenius Kabi Key News
7.4 Mallinckrodt Pharmaceuticals
  7.4.1 Mallinckrodt Pharmaceuticals Corporate Summary
  7.4.2 Mallinckrodt Pharmaceuticals Business Overview
  7.4.3 Mallinckrodt Pharmaceuticals Hepatic Encephalopathy Therapeutics Major Product Offerings
  7.4.4 Mallinckrodt Pharmaceuticals Hepatic Encephalopathy Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Mallinckrodt Pharmaceuticals Key News
7.5 Lupin
  7.5.1 Lupin Corporate Summary
  7.5.2 Lupin Business Overview
  7.5.3 Lupin Hepatic Encephalopathy Therapeutics Major Product Offerings
  7.5.4 Lupin Hepatic Encephalopathy Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Lupin Key News
7.6 Salix Pharmaceuticals
  7.6.1 Salix Pharmaceuticals Corporate Summary
  7.6.2 Salix Pharmaceuticals Business Overview
  7.6.3 Salix Pharmaceuticals Hepatic Encephalopathy Therapeutics Major Product Offerings
  7.6.4 Salix Pharmaceuticals Hepatic Encephalopathy Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Salix Pharmaceuticals Key News
7.7 Teva Pharmaceutical
  7.7.1 Teva Pharmaceutical Corporate Summary
  7.7.2 Teva Pharmaceutical Business Overview
  7.7.3 Teva Pharmaceutical Hepatic Encephalopathy Therapeutics Major Product Offerings
  7.7.4 Teva Pharmaceutical Hepatic Encephalopathy Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Teva Pharmaceutical Key News
7.8 Bausch Health
  7.8.1 Bausch Health Corporate Summary
  7.8.2 Bausch Health Business Overview
  7.8.3 Bausch Health Hepatic Encephalopathy Therapeutics Major Product Offerings
  7.8.4 Bausch Health Hepatic Encephalopathy Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Bausch Health Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Hepatic Encephalopathy Therapeutics Market Opportunities & Trends in Global Market
Table 2. Hepatic Encephalopathy Therapeutics Market Drivers in Global Market
Table 3. Hepatic Encephalopathy Therapeutics Market Restraints in Global Market
Table 4. Key Players of Hepatic Encephalopathy Therapeutics in Global Market
Table 5. Top Hepatic Encephalopathy Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hepatic Encephalopathy Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hepatic Encephalopathy Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hepatic Encephalopathy Therapeutics Product Type
Table 9. List of Global Tier 1 Hepatic Encephalopathy Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatic Encephalopathy Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Hepatic Encephalopathy Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hepatic Encephalopathy Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hepatic Encephalopathy Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Hepatic Encephalopathy Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hepatic Encephalopathy Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hepatic Encephalopathy Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Hepatic Encephalopathy Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hepatic Encephalopathy Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hepatic Encephalopathy Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hepatic Encephalopathy Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hepatic Encephalopathy Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hepatic Encephalopathy Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hepatic Encephalopathy Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hepatic Encephalopathy Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hepatic Encephalopathy Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hepatic Encephalopathy Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hepatic Encephalopathy Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hepatic Encephalopathy Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hepatic Encephalopathy Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. ASKA Pharmaceutical Corporate Summary
Table 31. ASKA Pharmaceutical Hepatic Encephalopathy Therapeutics Product Offerings
Table 32. ASKA Pharmaceutical Hepatic Encephalopathy Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. COSMO Pharmaceuticals Corporate Summary
Table 34. COSMO Pharmaceuticals Hepatic Encephalopathy Therapeutics Product Offerings
Table 35. COSMO Pharmaceuticals Hepatic Encephalopathy Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Fresenius Kabi Corporate Summary
Table 37. Fresenius Kabi Hepatic Encephalopathy Therapeutics Product Offerings
Table 38. Fresenius Kabi Hepatic Encephalopathy Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Mallinckrodt Pharmaceuticals Corporate Summary
Table 40. Mallinckrodt Pharmaceuticals Hepatic Encephalopathy Therapeutics Product Offerings
Table 41. Mallinckrodt Pharmaceuticals Hepatic Encephalopathy Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Lupin Corporate Summary
Table 43. Lupin Hepatic Encephalopathy Therapeutics Product Offerings
Table 44. Lupin Hepatic Encephalopathy Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Salix Pharmaceuticals Corporate Summary
Table 46. Salix Pharmaceuticals Hepatic Encephalopathy Therapeutics Product Offerings
Table 47. Salix Pharmaceuticals Hepatic Encephalopathy Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Teva Pharmaceutical Corporate Summary
Table 49. Teva Pharmaceutical Hepatic Encephalopathy Therapeutics Product Offerings
Table 50. Teva Pharmaceutical Hepatic Encephalopathy Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Bausch Health Corporate Summary
Table 52. Bausch Health Hepatic Encephalopathy Therapeutics Product Offerings
Table 53. Bausch Health Hepatic Encephalopathy Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Hepatic Encephalopathy Therapeutics Segment by Type in 2021
Figure 2. Hepatic Encephalopathy Therapeutics Segment by Application in 2021
Figure 3. Global Hepatic Encephalopathy Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hepatic Encephalopathy Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hepatic Encephalopathy Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hepatic Encephalopathy Therapeutics Revenue in 2021
Figure 8. By Type - Global Hepatic Encephalopathy Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hepatic Encephalopathy Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hepatic Encephalopathy Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hepatic Encephalopathy Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Hepatic Encephalopathy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hepatic Encephalopathy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hepatic Encephalopathy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hepatic Encephalopathy Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Hepatic Encephalopathy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Hepatic Encephalopathy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hepatic Encephalopathy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hepatic Encephalopathy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hepatic Encephalopathy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hepatic Encephalopathy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hepatic Encephalopathy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hepatic Encephalopathy Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Hepatic Encephalopathy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hepatic Encephalopathy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hepatic Encephalopathy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hepatic Encephalopathy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Hepatic Encephalopathy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hepatic Encephalopathy Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Hepatic Encephalopathy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hepatic Encephalopathy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hepatic Encephalopathy Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Hepatic Encephalopathy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hepatic Encephalopathy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hepatic Encephalopathy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hepatic Encephalopathy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. ASKA Pharmaceutical Hepatic Encephalopathy Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. COSMO Pharmaceuticals Hepatic Encephalopathy Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Fresenius Kabi Hepatic Encephalopathy Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Mallinckrodt Pharmaceuticals Hepatic Encephalopathy Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Lupin Hepatic Encephalopathy Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Salix Pharmaceuticals Hepatic Encephalopathy Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Teva Pharmaceutical Hepatic Encephalopathy Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bausch Health Hepatic Encephalopathy Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)